Compile Data Set for Download or QSAR
maximum 50k data
Found 157 with Last Name = 'batori' and Initial = 's'
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166453(US9073853, 12)
Affinity DataIC50:  13nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166545(US9073853, 104)
Affinity DataIC50:  15nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166528(US9073853, 87)
Affinity DataIC50:  19nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166446(US9073853, 5)
Affinity DataIC50:  19nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166447(US9073853, 6)
Affinity DataIC50:  20nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166475(US9073853, 34)
Affinity DataIC50:  22nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166529(US9073853, 88)
Affinity DataIC50:  23nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166466(US9073853, 25)
Affinity DataIC50:  25nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166455(US9073853, 14)
Affinity DataIC50:  25nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166589(US9073853, 148)
Affinity DataIC50:  26nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166477(US9073853, 36)
Affinity DataIC50:  28nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166450(US9073853, 9)
Affinity DataIC50:  32nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166457(US9073853, 16)
Affinity DataIC50:  35nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166445(US9073853, 4)
Affinity DataIC50:  37nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166456(US9073853, 15)
Affinity DataIC50:  37nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166448(US9073853, 7)
Affinity DataIC50:  38nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166474(US9073853, 33)
Affinity DataIC50:  42nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166458(US9073853, 17)
Affinity DataIC50:  44nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166517(US9073853, 76)
Affinity DataIC50:  45nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166516(US9073853, 75)
Affinity DataIC50:  45nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166523(US9073853, 82)
Affinity DataIC50:  46nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166530(US9073853, 89)
Affinity DataIC50:  52nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166471(US9073853, 30)
Affinity DataIC50:  53nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166546(US9073853, 105)
Affinity DataIC50:  53nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166460(US9073853, 19)
Affinity DataIC50:  55nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166510(US9073853, 69)
Affinity DataIC50:  56nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166567(US9073853, 126)
Affinity DataIC50:  58nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166465(US9073853, 24)
Affinity DataIC50:  58nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166441(US9073853, 1)
Affinity DataIC50:  60nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166444(US9073853, 3)
Affinity DataIC50:  60nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166504(US9073853, 63)
Affinity DataIC50:  62nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166467(US9073853, 26)
Affinity DataIC50:  64nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166451(US9073853, 10)
Affinity DataIC50:  64nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166459(US9073853, 18)
Affinity DataIC50:  64nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166484(US9073853, 43)
Affinity DataIC50:  68nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166595(US9073853, 154)
Affinity DataIC50:  70nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166563(US9073853, 122)
Affinity DataIC50:  70nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166526(US9073853, 85)
Affinity DataIC50:  71nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166598(US9073853, 157)
Affinity DataIC50:  71nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166558(US9073853, 117)
Affinity DataIC50:  71nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166550(US9073853, 109)
Affinity DataIC50:  73nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166478(US9073853, 37)
Affinity DataIC50:  76nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166508(US9073853, 67)
Affinity DataIC50:  77nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166597(US9073853, 156)
Affinity DataIC50:  79nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166468(US9073853, 27)
Affinity DataIC50:  80nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166481(US9073853, 40)
Affinity DataIC50:  81nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166469(US9073853, 28)
Affinity DataIC50:  81nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166554(US9073853, 113)
Affinity DataIC50:  82nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166534(US9073853, 93)
Affinity DataIC50:  84nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166527(US9073853, 86)
Affinity DataIC50:  85nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
Displayed 1 to 50 (of 157 total ) | Next | Last >>
Jump to: